Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             79 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abstracts author index 2008
14 p. 152-153
2 p.
artikel
2 Accessi venosi centrali: Inquadramento E Idicazioni Maiorino, L.
2008
14 p. 148-
1 p.
artikel
3 Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM) Galetta, D.
2008
14 p. 151-
1 p.
artikel
4 Acute non-lymphocytic leukemia: Onset after treatment for Hodgkin’s disease Santoro, M.
2008
14 p. 129-130
2 p.
artikel
5 Adjuvant chemotherapy of colon cancer current strategies Barone, Carlo
2008
14 p. 60-63
4 p.
artikel
6 A metronomic treatment with oral chemotherapy in patients elderly with metastatic breast cancer Vitello, S.
2008
14 p. 116-117
2 p.
artikel
7 Angiosarcoma of the right atrium: A case report D’Addetta, C.
2008
14 p. 145-
1 p.
artikel
8 Anxiety: A psychological observational study before mammography screening Barni, S.
2008
14 p. 147-
1 p.
artikel
9 Appropriateness of the use of PET/CT in the radiotherapy treatment planning for Hodgkin’s lymphoma Santoro, M.
2008
14 p. 118-
1 p.
artikel
10 Beta-erythropoietin in clinical practice: GOIM 2705 multicenter observational study Addeo, Raffaele
2008
14 p. 147-
1 p.
artikel
11 Bevacizumab+folfiri as first-line treatment in advanced colorectal cancer (ACC): A multicenter phase II study of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2601) Giuliani, F.
2008
14 p. 121-
1 p.
artikel
12 Bi-weekly administration of capecitabine+oxaliplatin (XELOX-2) in first line treatment of advanced colorectal cancer (ACRC): Preliminary results Di Bisceglie, M.
2008
14 p. 120-
1 p.
artikel
13 Cetuximab induced cutaneous rash: Does it affect psychological well-being in colorectal cancer patients? Romito, F.
2008
14 p. 122-
1 p.
artikel
14 Chemo-hormonal therapy for metastatic breast cancer patients: Treatment strategy Barni, S.
2008
14 p. 13-20
8 p.
artikel
15 Chemo-radiotherapy in locally advanced rectal cancer: What is the optimal strategy? Avallone, Antonio
2008
14 p. 70-73
4 p.
artikel
16 Circulating tumour cells in colorectal cancer Di Costanzo, Francesco
2008
14 p. 52-59
8 p.
artikel
17 Clinical results of EGFR-targeted therapies in advanced colorectal cancer Maiello, Evaristo
2008
14 p. 64-69
6 p.
artikel
18 Contribution of the functional imaging in the radiotherapy treatment planning for malignant glioma: Revision of the literature Santoro, M.
2008
14 p. 137-138
2 p.
artikel
19 Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer Ciccarese, Mariangela
2008
14 p. 4-9
6 p.
artikel
20 Coping with cancer: A prospective psycho-social analysis of cancer patients and their non-medical caregivers (cg) – A goim study Mistretta, G.
2008
14 p. 141-
1 p.
artikel
21 Correlation between basal bilirubin levels and survival in advanced colorectal carcinoma treated with CPT-11-based chemotherapy: A study of the Gruppo Oncologico Italia Meridionale (G.O.I.M.) Colucci, Giuseppe
2008
14 p. 94-99
6 p.
artikel
22 Current challenges and future perspectives in the medical treatment of solid tumours Sobrero, A.
2008
14 p. 140-
1 p.
artikel
23 Current challenges and future perspectives in the medical treatment of solid tumours Sobrero, A.
2008
14 p. 91-93
3 p.
artikel
24 CYR61 down-modulation sensitizes prostate cancer cells to zoledronic acid and docetaxel: A new anti-cancer strategy Caraglia, M.
2008
14 p. 123-124
2 p.
artikel
25 Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE Facchini, G.
2008
14 p. 124-
1 p.
artikel
26 DVD-based group information for cancer inpatients and families Romito, F.
2008
14 p. 148-149
2 p.
artikel
27 Editorial board 2008
14 p. ii-
1 p.
artikel
28 EGFR mutations in patients with non-small cell lung cancer (NSCLC) and correlation with sensitivity to erlotinib Ricciardi, S.
2008
14 p. 134-
1 p.
artikel
29 Electrochemotherapy (ECT) for the treatment of superficial tumour metastases Guida, M.
2008
14 p. 132-
1 p.
artikel
30 Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM) Giuliani, F.
2008
14 p. 107-112
6 p.
artikel
31 Evaluation of Folfox toxicity in a consecutive series of elderly cancer patients Tambaro, R.
2008
14 p. 128-
1 p.
artikel
32 Experience of 170 cases of ductal carcinoma in ‘ (DCIS) D’Addetta, C.
2008
14 p. 115-
1 p.
artikel
33 First-line cisplatin (P) with docetaxel (TXT) or vinorelbine (VNR) in patients with advanced non-small-cell lung cancer: A phase II randomized trial of Gruppo Oncologico Italia Meridionale Gebbia, V.
2008
14 p. 151-
1 p.
artikel
34 Folfiri versus xeliri in untreated advanced colorectal cancer: A phase II randomised trial of the Gruppo Oncologico dell’ Italia Meridionale (prot. GOIM 2405) Giuliani, F.
2008
14 p. 120-121
2 p.
artikel
35 Gastrointestinal stromal tumours: Two case reports Camplese, P.
2008
14 p. 119-
1 p.
artikel
36 High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data Conti, F.
2008
14 p. 115-
1 p.
artikel
37 High-dose chemotherapy as initial salvage treatment in relapsed testicular cancer patients Morelli, F.
2008
14 p. 124-125
2 p.
artikel
38 Image guided radiation therapy (IGRT) in the treatment planning of prostate cancer: Accuracy and precision of radiation therapy through modern imaging technologies Santoro, M.
2008
14 p. 125-126
2 p.
artikel
39 Imatinib in the treatment of dermatofibrosarcoma protuberans Fattoruso, S.I.S.
2008
14 p. 145-
1 p.
artikel
40 Improvement of pain and psychological status after six months of psychotherapy in cancer patients Tulipani, C.
2008
14 p. 148-
1 p.
artikel
41 Integrated regimen therapeutic (polybiologic-chemotherapy) for melanoma advanced Vitello, S.
2008
14 p. 135-
1 p.
artikel
42 Intravescical Gemcitabine versus Mitomycin for recurrent superficial bladder tumours (stages pTa and pT1): A randomized prospective study Faiola, Vincenzo
2008
14 p. 124-
1 p.
artikel
43 Is mammography screening anxiety related to personal coping style? Bonetti, M.L.
2008
14 p. 147-148
2 p.
artikel
44 Is oral metronomic cyclophosphamide (CTX) an effective palliative treatment for patients with metastatic breast carcinoma (ABC)? experience from a retrospective series of patients Boussen, H.
2008
14 p. 114-
1 p.
artikel
45 Laparoscopy in colon cancer: The new standard? Fumo, F.
2008
14 p. 100-101
2 p.
artikel
46 Making the right choice in the adjuvant chemotherapy of primary breast cancer Lopez, Massimo
2008
14 p. 10-12
3 p.
artikel
47 Malignant pleural mesothelioma: Scheme therapeutic after standard treatment (study of phase II) Vitello, S.
2008
14 p. 150-
1 p.
artikel
48 Management of toxicity in patients treated with tyrosine kinase inhibitors (TKI) Naglieri, Emanuele
2008
14 p. 42-45
4 p.
artikel
49 Merkel cell carcinoma Viola, G.
2008
14 p. 146-
1 p.
artikel
50 Metronomic oral Vinorelbine and Temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A Phase II study Montella, Liliana
2008
14 p. 116-
1 p.
artikel
51 Molecular and preclinical models enhancing anti-tumour activity of zoledronic acid Marra, M.
2008
14 p. 79-85
7 p.
artikel
52 Molecular biology of renal-cell carcinoma De Luca, Antonella
2008
14 p. 30-34
5 p.
artikel
53 Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patients Santini, Daniele
2008
14 p. 86-90
5 p.
artikel
54 Nuovo ruolo degli inibitori dell’aromatasi: Impiego in terapia adiuvante Molino, A.
2008
14 p. 115-116
2 p.
artikel
55 Oligometastases: A new reality in the therapy of the cancer Santoro, M.
2008
14 p. 139-
1 p.
artikel
56 Optimization of the therapeutic index through the integration among target therapy and radiotherapy Santoro, M.
2008
14 p. 142-144
3 p.
artikel
57 Palonosetron for prevention of acute and delayed nausea and vomiting induced by moderately emetogenic adjuvant folfox-4 regimen in colorectal cancer (CRC) patients: A phase II study of the Gruppo Oncologico dell’ Italia Meridionale (GOIM) Giuliani, F.
2008
14 p. 102-106
5 p.
artikel
58 Peritonectomy and intraoperative chemohypertermia as treatment of peritoneal carcinosis: Our experience Camplese, P.
2008
14 p. 132-133
2 p.
artikel
59 Pharmacogenetics in oncology Danesi, R.
2008
14 p. 74-78
5 p.
artikel
60 Pharmacogenetics in oncology Danesi, R.
2008
14 p. 139-
1 p.
artikel
61 Prognostic and predictive factors of breast carcinoma: Beyond hormonal receptors and HER2 Nappi, Oscar
2008
14 p. 1-3
3 p.
artikel
62 Prognostic factors in advanced renal cell cancer Porta, Camillo
2008
14 p. 35-37
3 p.
artikel
63 Radiochemotherapy for anal carcinoma: Our experience Morelli, F.
2008
14 p. 121-122
2 p.
artikel
64 Radiotherapy and temozolomide in glioblastoma: Predictive factors of response to the treatment Santoro, M.
2008
14 p. 136-137
2 p.
artikel
65 Rediscovering immunotherapy in combination with molecularly targeted agents in renal cell cancer Procopio, G.
2008
14 p. 125-
1 p.
artikel
66 Role of positron emission tomography (PET) in advanced stage non-small cell lung cancer patients treated with cisplatin-based doublets Gebbia, V.
2008
14 p. 150-
1 p.
artikel
67 Second-line chemotherapy in advanced cancer of the pancreas: A multicenter survey of the Gruppo Oncologico Italia Meridonale on the activity and safety of the folfiri regimen in clinical practice Arcara, C.
2008
14 p. 119-
1 p.
artikel
68 Second solid cancer after Hodgkin’s disease: Analysis of the risk and revision of the literature Santoro, M.
2008
14 p. 130-131
2 p.
artikel
69 Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study Del Prete, S.
2008
14 p. 119-120
2 p.
artikel
70 Sunitinib in advanced clear cell renal cancer: A single centre experience Bruni, G.S.
2008
14 p. 123-
1 p.
artikel
71 Tamoxifen in the treatment of recurrent, advanced border line ovarian cancer: A single centre experience Pisano, C.
2008
14 p. 125-
1 p.
artikel
72 Target therapy in metastatic renal cell carcinoma Cartenì, G.
2008
14 p. 38-41
4 p.
artikel
73 The burden of renal cell cancer: A retrospective longitudinal study on occurrence, outcomes and cost using an administrative claims database Mantovani, Lorenzo G
2008
14 p. 46-51
6 p.
artikel
74 The delay time in radiotherapy Santoro, M.
2008
14 p. 142-
1 p.
artikel
75 The role of bevacizumab in breast cancer Daniele, Gennaro
2008
14 p. 26-29
4 p.
artikel
76 Toward a new prognostic-therapeutic index in geriatric oncology Bellavia, M.
2008
14 p. 127-128
2 p.
artikel
77 Treatment in metastatic prostate cancer with hormone refractory Vitello, S.
2008
14 p. 1-
1 p.
artikel
78 Treatment of HER-2 positive breast cancer Clavarezza, Matteo
2008
14 p. 21-25
5 p.
artikel
79 Upfront aromatase inhibitors (AI) in early breast cancer: Against Boccardo, F.
2008
14 p. 113-114
2 p.
artikel
                             79 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland